|
C6ORF153 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.982000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.362900E-03 |
| Normal-vs-Stage2 |
5.739800E-01 |
| Normal-vs-Stage3 |
4.062700E-03 |
| Normal-vs-Stage4 |
1.581710E-03 |
| Stage1-vs-Stage2 |
3.718500E-02 |
| Stage1-vs-Stage3 |
7.679200E-01 |
| Stage1-vs-Stage4 |
1.730170E-01 |
| Stage2-vs-Stage3 |
4.770100E-02 |
| Stage2-vs-Stage4 |
1.944350E-02 |
| Stage3-vs-Stage4 |
3.233800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.823400E-03 |
| Normal-vs-AfricanAmerican |
5.319200E-01 |
| Normal-vs-Asian |
1.343690E-03 |
| Caucasian-vs-AfricanAmerican |
1.730560E-01 |
| Caucasian-vs-Asian |
2.780800E-01 |
| AfricanAmerican-vs-Asian |
3.374000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.644900E-03 |
| Normal-vs-Female |
3.457200E-03 |
| Male-vs-Female |
6.711200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.680700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.115540E-03 |
| Normal-vs-Age(61-80Yrs) |
4.821600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.836200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.403800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.191400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.171570E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.942200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.979400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.236300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.572600E-01 |
| Classical-VS-Follicular |
3.756200E-01 |
| Classical-VS-Other |
3.729800E-02 |
| Classical-VS-Normal |
6.537500E-03 |
| Tall-VS-Follicular |
9.115800E-01 |
| Tall-VS-Other |
1.175600E-01 |
| Tall-VS-Normal |
2.022300E-02 |
| Follicular-VS-Other |
2.023200E-01 |
| Follicular-VS-Normal |
6.264400E-03 |
| Other-VS-Normal |
4.499300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.865800E-02 |
| Normal-vs-N1 |
6.38929999999815E-05 |
| N0-vs-N1 |
3.302800E-03 |
|
|
